antipyrine has been researched along with oxazepam in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghuloum, AM; Jain, AN; Sage, CR | 1 |
| Coassolo, P; Lavé, T; Schneider, G | 1 |
| Ertl, P; Rohde, B; Selzer, P | 1 |
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Caron, G; Ermondi, G | 1 |
| Carrupt, PA; Martel, S; Ottaviani, G | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Albanus, L; Jönsson, M; Sparf, B | 1 |
| Kellermann, GH; Luyten-Kellermann, M | 1 |
| Andreasen, F; Andreasen, PB; Døssing, M; Loft, S; Sonne, J | 1 |
| Dorfeldt, A; Hamberg, O; Loft, S; Ovesen, L; Sonne, J | 1 |
| Andreasen, F; Dragsted, J; Døssing, M; Loft, S; Sonne, J | 1 |
| Denke, M; Inturrisi, CE; Wissel, PS | 1 |
| Benzi, G; Berté, F; Crema, A | 1 |
| Mascherpa, P | 1 |
| Andersen, V; Larsen, S; Sonne, J | 1 |
| Blanchard, N; Coassolo, P; Hewitt, NJ; Jones, H; Lavé, T; Silber, P | 1 |
2 trial(s) available for antipyrine and oxazepam
| Article | Year |
|---|---|
The effect of dietary energy and protein deficiency on drug metabolism.
Topics: Adult; Antipyrine; Biotransformation; Body Weight; Diet; Energy Metabolism; Glucuronates; Humans; Male; Metronidazole; Oxazepam; Oxidation-Reduction; Pharmaceutical Preparations; Protein Deficiency; Saliva | 1990 |
Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Chronic Disease; Coloring Agents; Female; GABA Modulators; Humans; Inactivation, Metabolic; Indocyanine Green; Male; Middle Aged; Models, Biological; Oxazepam; Pancreatitis; Statistics, Nonparametric | 1999 |
22 other study(ies) available for antipyrine and oxazepam
| Article | Year |
|---|---|
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.
Topics: Animals; Biological Availability; Dogs; Humans; Least-Squares Analysis; Liver; Multivariate Analysis; Neural Networks, Computer; Pharmacokinetics; Rats | 1999 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
Topics: Administration, Oral; Animals; Antipyrine; Behavior, Animal; Diazepam; Dogs; Drug Evaluation, Preclinical; Half-Life; Male; Oxazepam; Phenobarbital; Time Factors | 1977 |
On the regulation of antipyrine and oxazepam metabolism in man.
Topics: Antipyrine; Biotransformation; Female; Glucuronates; Half-Life; Humans; Male; Oxazepam | 1979 |
Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy.
Topics: Absorption; Adult; Antipyrine; Female; Glucuronates; Hepatic Encephalopathy; Humans; Male; Osmolar Concentration; Oxazepam | 1990 |
Influence of a very low calorie diet on the clearance of oxazepam and antipyrine in man.
Topics: Adult; Antipyrine; Body Weight; Chromatography, High Pressure Liquid; Diet, Reducing; Energy Intake; Female; Humans; Middle Aged; Obesity; Oxazepam | 1989 |
A comparison of the effects of a macrobiotic diet and a Western diet on drug metabolism and plasma lipids in man.
Topics: Adult; Antipyrine; Body Weight; Cholesterol; Diet; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Methadone; Oxazepam; Pharmaceutical Preparations | 1987 |
Investigation of hepatic drug metabolism by isolated perfused liver in situ.
Topics: Aminopyrine; Animals; Antipyrine; Dogs; Extracorporeal Circulation; Haplorhini; Liver; Oxazepam; Perfusion; Tranquilizing Agents | 1967 |
[Aspects of iatrogenic pharmacology and toxicology at the fetal level].
Topics: Aminopyrine; Amitriptyline; Animals; Anti-Bacterial Agents; Antipyrine; Diazepam; Dogs; Female; Fetal Diseases; Fetus; Glucuronates; Humans; Iatrogenic Disease; Oxazepam; Pregnancy; Rabbits; Rats; Tranquilizing Agents | 1969 |
Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.
Topics: Antipyrine; Bosentan; Cell Culture Techniques; Cryopreservation; Hepatocytes; Humans; Kinetics; Metabolic Clearance Rate; Models, Biological; Monte Carlo Method; Oxazepam; Pharmaceutical Preparations; Protein Binding; Reproducibility of Results; Serum; Sulfonamides | 2006 |